| Dr Daniel Martin Harwell, MD | |
|
6802 S Olympia Ave, Suite #300, Tulsa, OK 74132-1826 | |
| (918) 749-0762 | |
| (918) 744-4246 |
| Full Name | Dr Daniel Martin Harwell |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 7 Years |
| Location | 6802 S Olympia Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679890701 | NPI | - | NPPES |
| 200715920A | Medicaid | OK |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tulsa Spine & Specialty Hospital | Tulsa, OK | Hospital |
| Hillcrest Medical Center | Tulsa, OK | Hospital |
| Coffeyville Regional Medical Center, Inc | Coffeyville, KS | Hospital |
| Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Spine And Brain Institute | 8729090527 | 4 |
News Archive
In experiments with fruit flies, Johns Hopkins scientists have restored the insect's sperm-making stem cells by triggering cells on the way to becoming sperm to reverse course. The unexpected findings are described in the May 13 issue of Science.
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at CSIRO and experts at Geelong's Deakin University have found a way to "switch off" four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 1 days ago
| Entity Name | Ctca Physicans Group Of Oklahoma, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053309591 PECOS PAC ID: 2163328774 Enrollment ID: O20031212000074 |
News Archive
In experiments with fruit flies, Johns Hopkins scientists have restored the insect's sperm-making stem cells by triggering cells on the way to becoming sperm to reverse course. The unexpected findings are described in the May 13 issue of Science.
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at CSIRO and experts at Geelong's Deakin University have found a way to "switch off" four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 1 days ago
| Entity Name | Oklahoma Spine And Brain Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588625339 PECOS PAC ID: 8729090527 Enrollment ID: O20060616000270 |
News Archive
In experiments with fruit flies, Johns Hopkins scientists have restored the insect's sperm-making stem cells by triggering cells on the way to becoming sperm to reverse course. The unexpected findings are described in the May 13 issue of Science.
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at CSIRO and experts at Geelong's Deakin University have found a way to "switch off" four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Martin Harwell, MD 6802 S Olympia Ave, Suite #300, Tulsa, OK 74132-1826 Ph: (918) 749-0762 | Dr Daniel Martin Harwell, MD 6802 S Olympia Ave, Suite #300, Tulsa, OK 74132-1826 Ph: (918) 749-0762 |
News Archive
In experiments with fruit flies, Johns Hopkins scientists have restored the insect's sperm-making stem cells by triggering cells on the way to becoming sperm to reverse course. The unexpected findings are described in the May 13 issue of Science.
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at CSIRO and experts at Geelong's Deakin University have found a way to "switch off" four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
› Verified 1 days ago
Dr. Tyler Sean Auschwitz, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 South Wheeling, Ste 200, St. Johns Neuroscience Institute, Tulsa, OK 74104 Phone: 918-748-7854 | |
Joel Nathan Abramovitz, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 S Wheeling Ave, Suite 200, Tulsa, OK 74104 Phone: 918-748-7584 Fax: 918-293-3116 | |
Allan Gregory Rosenfeld, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2000 S Wheeling Ave, Ste 200, Tulsa, OK 74104 Phone: 918-748-7854 Fax: 918-293-3116 | |
Dr. Brian James Hood, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-744-2345 | |
Daniel James Boedeker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6767 S Yale Ave, Suite A, Tulsa, OK 74136 Phone: 918-492-7587 | |
Ryan Alexander Zengou, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6475 S Yale Ave Ste 308, Tulsa, OK 74136 Phone: 918-499-4000 Fax: 918-499-4001 | |
Mohammad Yashar S Kalani, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 S Wheeling Ave Ste 200, Tulsa, OK 74104 Phone: 918-748-7854 Fax: 918-403-6335 |